# Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study

> **NCT06162585** · — · ACTIVE_NOT_RECRUITING · sponsor: **Nanoscope Therapeutics Inc.** · enrollment: 18 (estimated)

## Conditions studied

- Retinitis Pigmentosa
- Retinitis
- Retinal Diseases
- Eye Diseases
- Eye Diseases, Hereditary
- Retinal Dystrophies
- Retinal Degeneration

## Interventions

- **BIOLOGICAL:** Gene Therapy product-MCO-010

## Key facts

- **NCT ID:** NCT06162585
- **Lead sponsor:** Nanoscope Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-12-08
- **Primary completion:** 2027-07
- **Final completion:** 2027-09
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06162585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06162585, "Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study". Retrieved via AI Analytics 2026-06-27 from https://api.ai-analytics.org/clinical/NCT06162585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*